MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
Holding MLTX?
Track your performance easily

MoonLake Immunotherapeutics (MLTX) Financial Statements

296 Followers

MoonLake Immunotherapeutics Financial Overview

MoonLake Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.904; its P/E ratio is -51.96; MoonLake Immunotherapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.68M$ -13.91M-$ -11.59M$ -12.34M
EBITDA$ -24.65M$ -13.88M-$ -11.59M-
Net Income Common Stockholders$ -24.27M$ -13.67M$ -4.89M$ -9.43M$ -10.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 519.80M$ 547.05M$ 511.01M$ 495.98M$ 501.79M
Total Assets$ 544.88M$ 564.12M$ 526.54M$ 500.22M$ 506.62M
Total Debt$ 3.34M$ 3.66M$ 3.70M$ 169.42K$ 211.24K
Net Debt$ -516.46M$ -543.39M$ -507.31M$ -495.81M$ -501.58M
Total Liabilities$ 14.85M$ 11.73M$ 13.05M$ 10.58M$ 7.51M
Stockholders Equity$ 520.66M$ 542.55M$ 495.68M$ 424.93M$ 489.80M
Cash Flow-
Free Cash Flow$ -27.89M$ -15.16M-$ -9.22M-
Operating Cash Flow$ -27.89M$ -14.95M$ -12.34M$ -9.22M-
Investing Cash Flow$ -87.74M$ -28.80M$ 116.87M$ -174.38M-
Financing Cash Flow-$ 50.98M$ 28.42M--
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

MoonLake Immunotherapeutics Debt to Assets

MoonLake Immunotherapeutics Cash Flow

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis